搜尋結果
Novartis leukemia drug more effective than older treatments in trial
Reuters· 4 日前, opens new tab said patients with a type of leukemia who took its Scemblix had a significantly ...
Council Post: Synthetic Data: A Path Toward Better Generative AI
Forbes· 4 日前In this article, I dive into synthetic data's ability to enhance generative AI's ...
Trump Conviction Shows Path For Criminal Charges Against Execs For Climate Claims
Forbes· 4 日前On May 30, a New York jury found former President Donald Trump guilty of 34 charges relating to ...
How To Become A Freelancer With No Experience In 2024
Forbes· 4 日前Approximately 70 million Americans have indicated that they will start freelancing in 2024, per ...
Spotify offers Car Thing refunds as it faces lawsuit over bricking the streaming device
TechCrunch· 5 日前... facing continued backlash over its decision to discontinue support for Car Thing, its in-c ...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters· 5 日前, opens new tab said on Thursday its drug Trodelvy, tested in patients with bladder cancer who ...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters· 5 日前, opens new tab said on Thursday the U.S. FDA had allowed expanded use of its cell therapy for ...
Judges did not ‘rubberstamp’ fees in $2.7 bln Blue Cross deal, US Supreme Court told
Reuters· 5 日前A U.S. appeals court did not “rubberstamp” a $667 million fee award for the attorneys behind a ...
Clorox and these other stocks are on the verge of marking a death cross chart pattern
CNBC· 5 日前A small group of stocks is on the verge of forming a worrisome chart pattern known as a ...
This Week In Credit Card News: High Interest Rates Hurting Consumers And Companies
Forbes· 5 日前This amounts to the largest single increase in debt-related costs and the highest cumulative ...